Company News For Nov 5, 2019

Zacks Equity Research Published on November 05, 2019

Shares of Wright Medical Group N.V. increased 31.9% after Stryker Corporation (SYK) announced a definitive agreement to acquire the medical device company.
Shares of Enlivex Therapeutics Ltd. (ENLV - Free Report) gained 15.7% after the clinical stage immunotherapy company announced positive interim safety and efficacy data from the continuing trial of off-the-shelf Allocetra in patients with severe sepsis.
Shares of Ceragon Networks Ltd. (CRNT - Free Report) declined 35.5% after the company posted Q3 earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.04.
Shares of Under Armour, Inc. (UAA - Free Report) lost 18.9% after the company said it was under federal investigation for its accounting practices.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.